Biogen price target raised to $251 from $237 at H.C. Wainwright
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
H.C. Wainwright raises BIIB target to $251; price around $205.74.
Target: $251
Posted price: $205.74
Analyst firm: H.C. Wainwright
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.